Article Menu

Export Article

More by Authors Links

Article Data

  • Views 61
  • Dowloads 8

This is a correction to: Signa Vitae. 2024; 20(5): 40-45. https://doi.org/10.22514/sv.2024.056

Corrections

Open Access

Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis

  • Semra Aytürk Salt1,*,
  • Nurettin Aydoğdu2
  • Ömer Salt3
  • Nihayet Fırat4
  • Necdet Süt5

1Department of Endocrinology and Metabolic Diseases, Kayseri City Hospital, 38080 Kayseri, Turkey

2Department of Medical Physiology, İnönü University, 44000 Malatya, Turkey

3Department of Emergency Medicine, Kayseri City Hospital, 38080 Kayseri, Turkey

4Department of Medical Physiology, Trakya University Medical Faculty, 22100 Edirne, Turkey

5Department of Biostatistics and Medical Information, Trakya University Medical Faculty, 22100 Edirne, Turkey

DOI: 10.22514/sv.2026.041 Vol.22,Issue 3,August 2026 pp.162-162

Published: 08 August 2026

*Corresponding Author(s): Semra Aytürk Salt E-mail: semra.ayturksalt@saglik.gov.tr

PDF (118.15 kB) View Full-text

Cite and Share

Salt SA, Aydoğdu N, Salt Ö, Fırat N, Süt N. Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. 2026; 22(3): 162-162. doi: 10.22514/sv.2026.041

URL:

https://www.signavitae.com/articles/10.22514/sv.2026.041

References

[1] Salt SA, Aydoğdu N, Salt Ö, Fırat N, Süt N. The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. 2024; 20: 40–45.

Submission Turnaround Time

Top